keyword
https://read.qxmd.com/read/38398257/low-density-lipoprotein-cholesterol-lowering-drugs-a-narrative-review
#21
REVIEW
Nicola Ferri, Massimiliano Ruscica, Sergio Fazio, Alberto Corsini
The modern history of cholesterol-lowering drugs started in 1972 when Dr. Akira Endo identified an active compound (compactin) that inhibited cholesterol biosynthesis from the culture broth of blue-green mold ( Penicillium citrinum Pen-51). Since 1987, statins have represented the milestone for the treatment of atherosclerotic cardiovascular disease. A new therapy for the treatment of hypercholesterolemia since the discovery of statins is ezetimibe, the first and only agent inhibiting intestinal cholesterol absorption...
February 7, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38376536/hyperlipidaemia-in-diabetes-are-there-particular-considerations-for-next-generation-therapies
#22
REVIEW
Sophie Béliard, Florian Mourre, René Valéro
Dyslipidaemias are major cardiovascular risk factors, especially in people with diabetes. In this area, next-generation therapies targeting circulating lipoparticle metabolism (LDL, VLDL, chylomicrons, HDL) have recently been approved by the European and US medical agencies, including anti- proprotein convertase subtilisin/kexin 9 (PCSK9) antibodies; an siRNA targeting PCSK9; bempedoic acid, which targets ATP citrate lyase; an antisense oligonucleotide targeting apolipoprotein C-III; an anti-angiopoietin-like 3 antibody; and a purified omega-3 fatty acid, icosapent ethyl...
February 20, 2024: Diabetologia
https://read.qxmd.com/read/38367082/early-starvation-in-european-seabass-dicentrarchus-labrax-larvae-has-no-drastic-effect-on-hepatic-intermediary-metabolism-in-juveniles
#23
JOURNAL ARTICLE
Khanakorn Phonsiri, Benjamin Geffroy, Jep Lokesh, Alexander Goikoetxea, Sandrine Skiba-Cassy, Stephane Panserat
The present study aims to investigate nutritional programming through early starvation in the European seabass (Dicentrarchus labrax). European seabass larvae were fasted at three different developmental periods for three durations from 60 to 65 dph (F1), 81 to 87 dph (F2), and 123 to 133 dph (F3). Immediate effects were investigated by studying gene expression of npy (neuropeptide Y) and avt (Arginine vasotocin) in the head, while potential long-term effects (i.e., programming) were evaluated on intermediary metabolism later in life (in juveniles)...
February 17, 2024: Fish Physiology and Biochemistry
https://read.qxmd.com/read/38342324/conjugation-to-gold-nanoparticles-of-methionine-gamma-lyase-a-cancer-starving-enzyme-physicochemical-characterization-of-the-nanocomplex-for-prospective-nanomedicine-applications
#24
JOURNAL ARTICLE
Samanta Raboni, Francesco Fumagalli, Giacomo Ceccone, Rita La Spina, Jessica Ponti, Dora Mehn, Giuditta Guerrini, Stefano Bettati, Andrea Mozzarelli, Mario D'Acunto, Gianluca Presciuttini, Caterina Cristallini, Edi Gabellieri, Patrizia Cioni
The pyridoxal 5'-dependent enzyme methionine γ-lyase (MGL) catalyzes the degradation of methionine. This activity has been profitable to develop an antitumor agent exploiting the strict dependence of most malignant cells on the availability of methionine. Indeed, methionine depletion blocks tumor proliferation and leads to an increased susceptibility to anticancer drugs. Here, we explore the conjugation of MGL to gold nanoparticles capped with citrate (AuNPs) as a novel strategy to deliver MGL to cancer cells...
February 9, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38294660/how-will-our-practice-change-after-the-clear-outcomes-trial
#25
REVIEW
Timothy Abrahams, Adam J Nelson, Stephen J Nicholls
PURPOSE OF REVIEW: Bempedoic acid is a novel therapeutic agent that is designed to reduce levels of low-density lipoprotein cholesterol (LDL-C). The purpose of this review is to provide the background for development of bempedoic acid, findings from clinical trials and to discuss clinical implications. RECENT FINDINGS: Bempedoic acid inhibits ATP citrate lyase within the liver and reduces cholesterol synthesis, with the potential to avoid muscle symptoms experienced by patients treated with statins...
January 31, 2024: Current Atherosclerosis Reports
https://read.qxmd.com/read/38275129/excess-phosphate-promotes-sars%C3%A2-cov%C3%A2-2-n-protein%C3%A2-induced-nlrp3-inflammasome-activation-via-the-scap%C3%A2-srebp2-signaling-pathway
#26
JOURNAL ARTICLE
Mi-Hua Liu, Xiao-Long Lin, Le-Le Xiao
Hyperphosphatemia or severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection can promote cardiovascular adverse events in patients with chronic kidney disease. Hyperphosphatemia is associated with elevated inflammation and sterol regulatory element binding protein 2 (SREBP2) activation, but the underlying mechanisms in SARS‑CoV‑2 that are related to cardiovascular disease remain unclear. The present study aimed to elucidate the role of excess inorganic phosphate (PI) in SARS‑CoV‑2 N protein‑induced NLRP3 inflammasome activation and the underlying mechanisms in vascular smooth muscle cells (VSMCs)...
March 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38260616/disease-associated-astrocyte-epigenetic-memory-promotes-cns-pathology
#27
Hong-Gyun Lee, Joseph M Rone, Zhaorong Li, Camilo Faust Akl, Seung Won Shin, Joon-Hyuk Lee, Lucas E Flausino, Florian Pernin, Chun-Cheih Chao, Kilian L Kleemann, Lena Srun, Tomer Illouz, Federico Giovannoni, Marc Charabati, Liliana M Sanmarco, Jessica E Kenison, Gavin Piester, Stephanie E J Zandee, Jack Antel, Veit Rothhammer, Michael A Wheeler, Alexandre Prat, Iain C Clark, Francisco J Quintana
Astrocytes play important roles in the central nervous system (CNS) physiology and pathology. Indeed, astrocyte subsets defined by specific transcriptional activation states contribute to the pathology of neurologic diseases, including multiple sclerosis (MS) and its pre-clinical model experimental autoimmune encephalomyelitis (EAE) 1-8 . However, little is known about the stability of these disease-associated astrocyte subsets, their regulation, and whether they integrate past stimulation events to respond to subsequent challenges...
January 5, 2024: bioRxiv
https://read.qxmd.com/read/38231501/impact-of-bempedoic-acid-on-total-cardiovascular-events-a-prespecified-analysis-of-the-clear-outcomes-randomized-clinical-trial
#28
JOURNAL ARTICLE
Stephen J Nicholls, Adam J Nelson, A Michael Lincoff, Danielle Brennan, Kausik K Ray, Leslie Cho, Venu Menon, Na Li, LeAnne Bloedon, Steven E Nissen
IMPORTANCE: The ATP citrate lyase (ACL) inhibitor, bempedoic acid, reduces low-density lipoprotein cholesterol (LDL-C) level and major adverse cardiovascular events (MACE) by 13% in patients at high cardiovascular risk with intolerance of statin and high-intensity statin medications. The effects of bempedoic acid on total cardiovascular events remain unknown. OBJECTIVE: To determine the impact of bempedoic acid on the total incidence of MACE. DESIGN, SETTING, AND PARTICIPANTS: Included in this prespecified analysis of the Cholesterol Lowering via Bempedoic Acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial were patients with, or at high risk for, cardiovascular disease, with hypercholesterolemia and inability to take guideline-recommended statins...
January 17, 2024: JAMA Cardiology
https://read.qxmd.com/read/38223990/the-futile-creatine-cycle-and-the-synthesis-of-fatty-acids-in-inguinal-white-adipose-tissue-from-growing-rats-submitted-to-a-hypoprotein-hyperglycidic-diet-for-15%C3%A2-days
#29
JOURNAL ARTICLE
Edgar Willibaldo Allebrandt Neto, Jadyellen Rondon E Silva, Stephanie Figueiredo Santos, Suélem Aparecida de França Lemes, Nair Honda Kawashita, Mayara Peron Pereira
The low-protein, high-carbohydrate (LPHC) diet administered to growing rats soon after weaning, for 15 days, promoted an increase in energy expenditure by uncoupling protein 1 (UCP1) in interscapular brown adipose tissue, and also due to the occurrence of the browning process in the perirenal white adipose tissue (periWAT). However, we believe that inguinal white adipose tissue (ingWAT) may also contribute to energy expenditure through other mechanisms. Therefore, the aim of this work is to investigate the presence of the futile creatine cycle, and the origin of lipids in ingWAT, since that tissue showed an increase in the lipids content in rats submitted to the LPHC diet for 15 days...
January 15, 2024: Lipids
https://read.qxmd.com/read/38212033/-mechanism-of-danggui-sini-decoction-in-improving-kidney-injury-caused-by-blood-stasis-syndrome-based-on-metabolomics-and-network-pharmacology
#30
JOURNAL ARTICLE
Lin-Lin Feng, Si-Qi Tang, Yun-Yuan Nong, Ying He, Qian-Yi Wang, Jing-Hua Qin, Yue Guo, Zhi-Heng Su
This article analyzed the mechanism of Danggui Sini Decoction(DSD) in improving kidney injury caused by blood stasis syndrome(BSS) in rats. Firstly, 32 female SD rats were randomly divided into the following four groups: a normal group and a BSS group, both receiving an equal amount of distilled water by gavage; a normal+DSD group and a BSS+DSD group, both receiving 5.103 g·kg~(-1) DSD orally for a total of 14 days. Daily cold water bath was given to establish the BSS model, and on the 14th day, BSS rats were subcutaneously injected with 0...
December 2023: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38193847/oxidized-low-density-lipoprotein-accumulation-in-macrophages-impairs-lipopolysaccharide-induced-activation-of-akt2-atp-citrate-lyase-acetyl-coenzyme-a-production-and-inflammatory-gene-h3k27-acetylation
#31
JOURNAL ARTICLE
Kenneth K Y Ting, Pei Yu, Mudia Iyayi, Riley Dow, Sharon J Hyduk, Eric Floro, Hisham Ibrahim, Saraf Karim, Chanele K Polenz, Daniel A Winer, Minna Woo, Jonathan Rocheleau, Jenny Jongstra-Bilen, Myron I Cybulsky
The accumulation of lipid and the formation of macrophage foam cells is a hallmark of atherosclerosis, a chronic inflammatory disease. To better understand the role of macrophage lipid accumulation in inflammation during atherogenesis, we studied early molecular events that follow the accumulation of oxidized low-density lipoprotein (oxLDL) in cultured mouse macrophages. We previously showed that oxLDL accumulation downregulates the inflammatory response in conjunction with downregulation of late-phase glycolysis...
January 1, 2024: ImmunoHorizons
https://read.qxmd.com/read/38184174/formyl-phloroglucinol-meroterpenoids-from-the-leaves-of-eucalyptus-globulus-subsp-maidenii-and-their-atp-citrate-lyase-inhibitory-activities
#32
JOURNAL ARTICLE
Zhu Hu, Yi-Nan Liu, Mei-Hua Yu, Ai-Jun Hou, Jing-Ya Li, Ying-Xia Li, Chun Lei
Three new formyl phloroglucinol meroterpenoids, eumaidials A-C (1-3), were isolated from the leaves of Eucalyptus globulus subsp. maidenii, along with ten known analogues (4-13). Their chemical structures were determined by various spectral data and electronic circular dichroism calculations. Eumaidial A (1) is the first β-caryophyllene-based formyl phloroglucinol meroterpenoids from the genus Eucalyptus. Compounds 1-4 and 10 exhibited ATP-citrate lyase inhibitory activities, and compounds 2 and 3 suppressed the hepatocyte lipogenesis...
January 4, 2024: Fitoterapia
https://read.qxmd.com/read/38183482/high-level-biosynthesis-of-enantiopure-germacrene-d-in-yeast
#33
JOURNAL ARTICLE
Shubha Sharma, Seema Chaurasia, Sandeep Dinday, Gaurav Srivastava, Anamika Singh, Chandan Singh Chanotiya, Sumit Ghosh
Germacrene D, a sesquiterpenoid compound found mainly in plant essential oils at a low level as (+) and/or (-) enantiomeric forms, is an ingredient for the fragrance industry, but a process for the sustainable supply of enantiopure germacrene D is not yet established. Here, we demonstrate metabolic engineering in yeast (Saccharomyces cerevisiae) achieving biosynthesis of enantiopure germacrene D at a high titer. To boost farnesyl pyrophosphate (FPP) flux for high-level germacrene D biosynthesis, a background yeast chassis (CENses5C) was developed by genomic integration of the expression cassettes for eight ergosterol pathway enzymes that sequentially converted acetyl-CoA to FPP and by replacing squalene synthase promoter with a copper-repressible promoter, which restricted FPP flux to the competing pathway...
December 2024: Applied Microbiology and Biotechnology
https://read.qxmd.com/read/38176897/atp-citrate-lyase-acly-dependent-immunometabolism-in-mucosal-t-cells-drives-experimental-colitis-in-vivo
#34
JOURNAL ARTICLE
Anja Schulz-Kuhnt, Katharina Rühle, Asal Javidmehr, Michael Döbrönti, Jana Biwank, Selina Knittel, Peter Neidlinger, Jannik Leupold, Li-Juan Liu, Mark Dedden, Regina Verena Taudte, Arne Gessner, Martin F Fromm, Dirk Mielenz, Lucas Kreiss, Maximilian J Waldner, Sebastian Schürmann, Oliver Friedrich, Barbara Dietel, Rocío López-Posadas, Christina Plattner, Sebastian Zundler, Christoph Becker, Raja Atreya, Markus F Neurath, Imke Atreya
OBJECTIVE: Mucosal T cells play a major role in inflammatory bowel disease (IBD). However, their immunometabolism during intestinal inflammation is poorly understood. Due to its impact on cellular metabolism and proinflammatory immune cell function, we here focus on the enzyme ATP citrate lyase (ACLY) in mucosal T cell immunometabolism and its relevance for IBD. DESIGN: ACLY expression and its immunometabolic impact on colitogenic T cell function were analysed in mucosal T cells from patients with IBD and in two experimental colitis models...
January 4, 2024: Gut
https://read.qxmd.com/read/38159295/conquering-cholesterol-a-report-from-the-front-lines
#35
JOURNAL ARTICLE
Peter Libby, Stephen L Pinkosky, Steven E Nissen
No abstract text is available yet for this article.
December 30, 2023: Cardiovascular Research
https://read.qxmd.com/read/38142252/monoamine-oxidase-mediated-oxidative-stress-a-potential-molecular-and-biochemical-crux-in-the-pathogenesis-of-obesity
#36
REVIEW
J P Shirley Niveta, Cordelia Mano John, Sumathy Arockiasamy
Obesity has become a global health concern with an increasing prevalence as years pass by but the researchers have not come to a consensus on the exact pathophysiological mechanism underlying this disease. In the past three decades, Monoamine Oxidases (MAO), has come into limelight for a possible involvement in orchestrating the genesis of obesity but the exact mechanism is not well elucidated. MAO is essentially an enzyme involved in the catabolism of neurotransmitters and other biogenic amines to form a corresponding aldehyde, hydrogen peroxide (H2 O2 ) and ammonia...
December 23, 2023: Molecular Biology Reports
https://read.qxmd.com/read/38114406/corrigendum-to-preparation-and-identification-of-isoquinoline-alkaloids-with-atp-citrate-lyase-inhibitory-activity-from-dactylicapnos-scandens-fitoterapia165-2023-105397
#37
Hui Jiang, Tao Hou, Yan Han, Shu-Bin Lu, Lei Liu, Ding-Xiang Li, Yun-Hui Zhu, Hang Huang, Wen-Jie Li, Xing-Ya Xue, Yan-Fang Liu, Xin-Miao Liang
No abstract text is available yet for this article.
December 18, 2023: Fitoterapia
https://read.qxmd.com/read/38095480/bempedoic-acid-a-new-player-for-statin-intolerant-patients-and-beyond
#38
REVIEW
Salvatore Giordano, Carmen Anna Maria Spaccarotella, Giovanni Esposito, Ciro Indolfi
PURPOSE OF REVIEW: Low-density lipoproteins (LDL) cause atherosclerotic cardiovascular disease, a condition associated with significant morbidity and mortality. Statins represent the cornerstone for preventing cardiovascular events in patients with elevated LDL-cholesterol (LDL-C) levels, however, they are associated with frequent musculoskeletal adverse effects, which lead to drug discontinuation or limit their use to low (and less effective) doses. Bempedoic acid (BA) is a newly approved, safe, cholesterol-lowering agent that inhibits ATP-citrate lyase, an enzyme upstream to 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, the target of statins...
April 1, 2024: Current Opinion in Endocrinology, Diabetes, and Obesity
https://read.qxmd.com/read/38085172/bempedoic-acid-new-evidence-and-recommendations-on-use
#39
REVIEW
Kristina Paponja, Ivan Pećin, Željko Reiner, Maciej Banach
PURPOSES OF REVIEW: Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity worldwide. Recognizing the importance of dyslipidemia treatment in the prevention of cardiovascular events has become a part of standard clinical practice. Desired values of LDL cholesterol (LDL-C) have become lower and lower in the last few decades, as evidenced by the most recent guidelines. Therefore, efforts to lower LDL cholesterol concentrations with conventional therapies and combinations of lipid-lowering therapy may not be successful in a high proportion of patients...
February 1, 2024: Current Opinion in Lipidology
https://read.qxmd.com/read/38075064/pfos-elicited-metabolic-perturbation-in-liver-and-fatty-acid-metabolites-in-testis-of-adult-mice
#40
JOURNAL ARTICLE
Wang Ka Lee, Thomas Ka Yam Lam, Hiu Ching Tang, Tsz Chun Ho, Hin Ting Wan, Chris Kong Chu Wong
INTRODUCTION: Multiple factors can contribute to sub-fecundity, including genetics, lifestyle, and environmental contaminants. PFASs are characterized as "forever chemicals" due to their ubiquitous contamination and their persistence in the environment, wildlife, and humans. Numerous studies have demonstrated that PFAS exposure adversely affects multiple bodily functions, including liver metabolism and gonadal function. It is unclear, however, how the disruption of hepatic fatty acid metabolism affects testicular function...
2023: Frontiers in Endocrinology
keyword
keyword
114681
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.